RHOT1 Plays Critical Role in Gastric Cancer Progression

Researchers at the People's Hospital of Liaoning Province have discovered a link between the protein RHOT1 and gastric cancer progression. The study, published in the International Journal of Oncology, found that RHOT1 regulates mitochondrial dynamics and energy metabolism, and its silencing reduced mRNA expression by 59.75% and protein expression by 65.12% in gastric cancer cells. This led to suppressed mitophagy and an 84.73% increase in reactive oxygen species.

Key Takeaways:

• RHOT1 plays a critical role in regulating mitochondrial dynamics and energy metabolism in gastric cancer cells.
• Silencing RHOT1 reduced mRNA expression by 59.75% and protein expression by 65.12%, leading to suppressed mitophagy.
• The study found an 84.73% increase in reactive oxygen species in gastric cancer cells after silencing RHOT1.
• The research suggests that RHOT1 may serve as a biomarker for prognostic assessment and individualized treatment of gastric cancer.
• The study used qPCR and western blotting to evaluate gene and protein expression, and siRNA transfection to silence RHOT1.
• The research also employed flow cytometry, CCK-8 proliferation, wound-healing, and Transwell assays to investigate mitochondrial function and cellular phenotypes.

Statistics:

• 59.75% reduction in mRNA expression after silencing RHOT1 (P=0.025)
• 65.12% reduction in protein expression after silencing RHOT1 (P=0.0189)
• 84.73% increase in reactive oxygen species after silencing RHOT1 (P=<0.001)

Sources:

• International Journal of Oncology, 2025;67(6)
• Spandidos Publ Ltd, Pob 18179, Athens, 116 10, Greece
• People's Hospital of Liaoning Province, Shenyang, Liaoning 110016, People's Republic of China
• Xiaoming Chen, Dept. of Cardiology, People's Hospital of China Medical University
• International Journal of Oncology can be contacted at: Spandidos Publ Ltd, Pob 18179, Athens, 116 10, Greece